[an error occurred while processing this directive]
临床研究

亚洲地区维持性血液透析患者肌少症患病率及影响因素的Meta分析

  • 何莉 ,
  • 陈林 ,
  • 张颖君 ,
  • 陈辉 ,
  • 李超
展开
  • 1四川大学华西医院肾脏内科血液透析中心,国家老年疾病临床医学研究中心
    2四川大学华西护理学院

收稿日期: 2021-02-18

  修回日期: 2021-05-13

  网络出版日期: 2021-07-21

基金资助

国家老年疾病临床医学研究中心(四川大学华西医院)立项资助课题(Z20192012)

Meta analysis of the prevalence and influencing factors of sarcopenia in maintenance hemodialysis patients in Asia

  • HE Li ,
  • CHEN Lin ,
  • ZHANG Ying-Jun ,
  • CHEN Hui ,
  • LI Chao
Expand
  • 1Hemodialysis Center, Department of Nephrology, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu 610041, China;  2West China School of Nursing, Sichuan University, Chengdu 610041, China

Received date: 2021-02-18

  Revised date: 2021-05-13

  Online published: 2021-07-21

摘要

【摘要】目的系统评价亚洲地区维持性血液透析患者肌少症的患病率和影响因素。方法  计算机检索PubMed、Embase、Web of science、Cochrane Library、中国知网、中国生物医学文献数据库、维普和万方数据库从建库至2020 年10 月关于亚洲地区维持性血液透析(maintenance hemodialysis,MHD)患者肌少症影响因素的研究,使用Stata 15.1 软件进Meta 分析。结果共纳入10 篇文献,研究对象1830 例,文献质量为中高等。Meta 分析显示亚洲地区MHD 患者肌少症的患病率为33%(95% CI:0.227~0.428),其中国内MHD 患者肌少症的患病率为32%(95% CI:0.198~0.437)。年龄(OR=0.850,95% CI:0.630~1.070,P<0.001)、透析龄(OR= 0.396, 95% CI:0.090~0.701,P=0.011)、改良主观全面营养评价(OR=0.886,95% CI:0.694~1.077,P<0.001)、血清磷(OR=﹣0.613,95% CI:﹣0.877~﹣0.349,P<0.001)与肌少症独立相关。结论亚洲地区MHD 患者肌少症的患病率较高,高龄、长透析龄、营养不良及低血清磷水平是MHD患者肌少症发生的危险因素,应对此类患者及早进行干预。

本文引用格式

何莉 , 陈林 , 张颖君 , 陈辉 , 李超 . 亚洲地区维持性血液透析患者肌少症患病率及影响因素的Meta分析[J]. 中国血液净化, 2021 , 20(07) : 455 -459 . DOI: 10.3969/j.issn.1671-4091.2021.07.006

Abstract

【Abstract】Objective A systematic review of the prevalence and influencing factors of sarcopenia in maintenance hemodialysis (MHD) patients in Asia. Methods Computer search of PubMed, Embase, Web of Science, Cochrane Library, CNKI, China Biomedical Literature Database, VIP and Wanfang Database from the establishment of the database to October 2020 for the prevalence and influencing factors of sarcopenia in maintenance hemodialysis (MHD) patients in Asia was conducted. Stata 15.1 software was used for meta analysis. Results A total of 10 articles were enrolled, including 1,830 subjects, and the quality of the literature was medium to high. Meta analysis showed that the prevalence of sarcopenia in MHD patients in Asia was 33% (95% CI 0.227~0.428), and the prevalence of sarcopenia in MHD patients in China was 32% (95% CI 0.198~0.437). The influencing factors of sarcopenia included age (OR=0.850, 95% CI 0.630~1.070, P<0.001), dialysis duration (OR=0.396, 95% CI 0.090~0.701, P= 0.011), modified quantitative subjective global nutrition evaluation assessment (MQSGA) score (OR=0.886, 95% CI 0.694~1.077, P<0.001) and serum phosphorus (OR=-0.613, 95% CI -0.877~-0.349, P<0.001). Conclusion The prevalence of sarcopenia in
MHD patients in Asia was high. Older age, longer dialysis age, malnutrition, and lower serum phosphorus level were the risk factors for sarcopenia in MHD patients. Sarcopenia in MHD patients should be treated as early as possible.

参考文献

[1]Niang A, Iyengar A, Luyckx V A.Hemodialysis versus peritoneal dialysis in resource-limited settings[J].Curr Opin Nephrol Hypertens, 2018, 27(6):463-471 [2]Saran R, Robinson B, Abbott K C, et al.US Renal Data System 2017 Annual Data Report: Epidemiology of Kidney Disease in the United States[J].Am J Kidney Dis, 2018, 71(3 Suppl 1):A7- [3]Cruz-Jentoft A J, Sayer A A.Sarcopenia[J].The Lancet, 2019, 393(10191):2636-2646 [4]张琦, 秦海峰, 简桂花.老年血液透析患者肌少症临床特点及危险因素分析[J].中华老年医学杂志, 2020, 39(09):1046-1049 [5]Lin Y-L, Liou H-H, Wang C-H, et al.Impact of sarcopenia and its diagnostic criteria on hospitalization and mortality in chronic hemodialysis patients: A 3-year longitudinal study[J].Journal of the Formosan Medical Association, 2020, 119(7):1219-1229 [6]Toyoda K, Kuragano T, Kawada H, et al.Effect of Progression in Malnutrition and Inflammatory Conditions on Adverse Events and Mortality in Patients on Maintenance Hemodialysis[J].Blood Purification, 2019, 47(Suppl. 2):3-11 [7]Lou X, Li Y, Shen H, et al.Physical activity and somatic symptoms among hemodialysis patients: a multi-center study in Zhejiang,China[J].BMC Nephrol, 2019, 20(1):477- [8]Fahal I H.Uraemic sarcopenia: aetiology and implications[J].Nephrol Dial Transplant, 2014, 29(9):1655-65 [9]Chen L K, Liu L K, Woo J, et al.Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia[J].J Am Med Dir Assoc, 2014, 15(2):95-101 [10]Chen L K, Woo J, Assantachai P, et al.Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment[J].J Am Med Dir Assoc, 2020, 21(3):300-307 [11]Cruz-Jentoft A J, Baeyens J P, Bauer J M, et al.Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People[J].Age Ageing, 2010, 39(4):412-23 [12]Cruz-Jentoft A J, Bahat G, Bauer J, et al.Sarcopenia: revised European consensus on definition and diagnosis[J].Age Ageing, 2019, 48(1):16-31 [13]曾宪涛, 刘慧, 陈曦.分析系列之四:观察性研究的质量评价工具[J].中国循证心血管医学杂志, 2012, 4(04):297-299 [14]Kim J K, Choi S R, Choi M J, et al.Prevalence of and factors associated with sarcopenia in elderly patients with end-stage renal disease[J].Clin Nutr, 2014, 33(1):64-8 [15] Hongqi R, Dehua G, Fengyu J, et al.Sarcopenia in patients undergoing maintenance hemodialysis: incidence rate, risk factors and its effect on survival risk[J]. Renal failure, 2016, 38(3).[J].Renal failure, 2016, 38(3):364-371 [16] Lin Y-L, Liou H-H, Lai Y-H, et al.Decreased serum fatty acid binding protein 4 concentrations are associated with sarcopenia in chronic hemodialysis patients[J]. Clinica Chimica Acta, 2018, 485: 113-118.[J].Clinica Chimica Acta, 2018, 485:113-118 [17]Mori K, Nishide K, Okuno S, et al.Impact of diabetes on sarcopenia and mortality in patients undergoing hemodialysis[J].BMC Nephrol, 2019, 20(1):105- [18] Cheng D, Zhang Q, Wang Z, et al.Association Between Sarcopenia and Its Components and Dependency in Activities of Daily Living in Patients on Hemodialysis[J]. J Ren Nutr, 2020.[J]. J Ren Nutr, 2020, :- [19]王亚美, 邢利, 程艳.维持性血液透析患者肌肉减少症的危险因素及预后研究[J].中国实用内科杂志, 2020, 40(05):396-400 [20]刘丹, 张红梅, 范汝艳.维持性血液透析患者肌肉减少症调查及影响因素分析[J].中国中西医结合肾病杂志, 2018, 19(04):329-332 [21]董志娟, 张海林.维持性血液透析患者肌少症发生的危险因素分析[J].护理学杂志, 2018, 33(09):20-24 [22]黄丽娅, 李少华, 翁敏.维持性血液透析病人骨骼肌减少症发生率和危险因素研究[J].肠外与肠内营养, 2017, 24(02):78-81 [23]Yoowannakul S, Tangvoraphonkchai K, Vongsanim S, et al.Differences in the prevalence of sarcopenia in haemodialysis patients: the effects of gender and ethnicity[J].Journal of Human Nutrition and Dietetics, 2018, 31(5):689-696 [24]Tsutsumimoto K, Doi T, Nakakubo S, et al.Association between anorexia of ageing and sarcopenia among Japanese older adults[J].J Cachexia Sarcopenia Muscle, 2020, 11(5):1250-1257 [25] Domanski M, Ciechanowski K.Sarcopenia: a major challenge in elderly patients with end-stage renal disease[J]. Journal of aging research, 2012, 2012: 754739-754739.[J].Journal of aging research, 2012, :- [26]Woo J.Sarcopenia[J].Clin Geriatr Med, 2017, 33(3):305-314 [27] Mo Y H, Zhong J, Dong X, et al.Comparison of Three Screening Methods for Sarcopenia in Community-Dwelling Older Persons[J]. J Am Med Dir Assoc, 2020.[J].J Am Med Dir Assoc, 2020, :- [28]Agarwal E, Miller M, Yaxley A, et al.Malnutrition in the elderly: a narrative review[J].Maturitas, 2013, 76(4):296-302 [29]Giglio J, Kamimura M A, Lamarca F, et al.Association of Sarcopenia With Nutritional Parameters,Quality of Life,Hospitalization,and Mortality Rates of Elderly Patients on Hemodialysis[J].J Ren Nutr, 2018, 28(3):197-207 [30] Chen S C, Chung W S, Wu P Y, et al.Associations among Geriatric Nutrition Risk Index, bone mineral density, body composition and handgrip strength in patients receiving hemodialysis[J]. Nutrition, 2019, 65: 6-12.[J].Nutrition, 2019, 65:6-12 [31]Gebrie M H, Ford J.Depressive symptoms and dietary non-adherence among end stage renal disease patients undergoing hemodialysis therapy: systematic review[J].BMC Nephrol, 2019, 20(1):429- [32]Noghan N, Akaberi A, Pournamdarian S, et al.Resilience and therapeutic regimen compliance in patients undergoing hemodialysis in hospitals of Hamedan,Iran[J].Electron Physician, 2018, 10(5):6853-6858 [33]Kalantar-Zadeh K, Kleiner M, Dunne E, et al.A modified quantitative subjective global assessment of nutrition for dialysis patients[J].Nephrol Dial Transplant, 1999, 14(7):1732-8 [34] Feray G, Hilal Y, Yasemin E.Association of Malnutrition Inflammation Score With Anthropometric Parameters, Depression, and Quality of Life in Hemodialysis Patients[J]. Journal of the American College of Nutrition, 2019, 38(5).[J].Journal of the American College of Nutrition, 2019, 38(5):- [35]Dhillon R J, Hasni S.Pathogenesis and Management of Sarcopenia[J].Clin Geriatr Med, 2017, 33(1):17-26 [36]Robinson S M, Reginster J Y, Rizzoli R, et al.Does nutrition play a role in the prevention and management of sarcopenia?[J].Clin Nutr, 2018, 37(4):1121-1132 [37]Bousquet-Santos K, Da Costa L D G, De Leon Andrade J M.Nutritional status of individuals with chronic renal failure in hemodialysis in the Unified Health System[J].Ciencia & Saude Coletiva, 2019, 24(3):1189-1199 [38]Chao C T, Tang C H, Cheng R W, et al.Protein-energy wasting significantly increases healthcare utilization and costs among patients with chronic kidney disease: a propensity-score matched cohort study[J].Curr Med Res Opin, 2017, 33(9):1705-1713 [39]Fouque D, Horne R, Cozzolino M, et al.Balancing nutrition and serum phosphorus in maintenance dialysis[J].Am J Kidney Dis, 2014, 64(1):143-50
文章导航

/

[an error occurred while processing this directive]